These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1109 related articles for article (PubMed ID: 9796632)

  • 41. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population.
    Chatzimichalis M; Xenellis J; Tzagaroulakis A; Sarof P; Banis K; Gazouli M; Bibas A
    J Laryngol Otol; 2010 Mar; 124(3):318-23. PubMed ID: 19922706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan.
    Lee CN; Yu MC; Bai KJ; Chang JH; Fang CL; Hsu HL; Huang BS; Lu PC; Liu HE
    Lung Cancer; 2009 Apr; 64(1):9-12. PubMed ID: 18706736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.
    Hou SM; Ryberg D; Fält S; Deverill A; Tefre T; Børresen AL; Haugen A; Lambert B
    Carcinogenesis; 2000 Jan; 21(1):49-54. PubMed ID: 10607733
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.
    Hirvonen A; Saarikoski ST; Linnainmaa K; Koskinen K; Husgafvel-Pursiainen K; Mattson K; Vainio H
    J Natl Cancer Inst; 1996 Dec; 88(24):1853-6. PubMed ID: 8961976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in Central Europe.
    McKay JD; Hashibe M; Hung RJ; Wakefield J; Gaborieau V; Szeszenia-Dabrowska N; Zaridze D; Lissowska J; Rudnai P; Fabianova E; Mates D; Foretova L; Janout V; Bencko V; Chabrier A; Hall J; Boffetta P; Canzian F; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):141-7. PubMed ID: 18199719
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
    Osawa Y; Osawa KK; Miyaishi A; Higuchi M; Tsutou A; Matsumura S; Tabuchi Y; Tsubota N; Takahashi J
    Asian Pac J Cancer Prev; 2007; 8(1):103-8. PubMed ID: 17477782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homozygous rapid arylamine N-acetyltransferase (NAT2) genotype as a susceptibility factor for lung cancer.
    Cascorbi I; Brockmöller J; Mrozikiewicz PM; Bauer S; Loddenkemper R; Roots I
    Cancer Res; 1996 Sep; 56(17):3961-6. PubMed ID: 8752164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current smoking, occupation, N-acetyltransferase-2 and bladder cancer: a pooled analysis of genotype-based studies.
    Vineis P; Marinelli D; Autrup H; Brockmoller J; Cascorbi I; Daly AK; Golka K; Okkels H; Risch A; Rothman N; Sim E; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1249-52. PubMed ID: 11751441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer.
    Habalová V; Salagovic J; Kalina I; Stubna J
    Neoplasma; 2005; 52(5):364-8. PubMed ID: 16151580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking.
    Tsukino H; Nakao H; Kuroda Y; Imai H; Inatomi H; Osada Y; Katoh T
    Eur J Cancer Prev; 2004 Dec; 13(6):509-14. PubMed ID: 15548945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk.
    Millikan RC; Pittman GS; Newman B; Tse CK; Selmin O; Rockhill B; Savitz D; Moorman PG; Bell DA
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):371-8. PubMed ID: 9610785
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
    McGrath M; Michaud D; De Vivo I
    BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of glutathione S-transferase M1 polymorphisms and lung cancer risk in a Chinese population.
    Liu D; Wang F; Wang Q; Guo X; Xu H; Wang W; Zhang L
    Clin Chim Acta; 2012 Dec; 414():188-90. PubMed ID: 23000285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [CYP1A1 polymorphisms, lack of glutathione S-transferase M1 (GSTM1), cooking oil fumes and lung cancer risk in non-smoking women].
    Zhu XX; Hu CP; Gu QH
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Nov; 33(11):817-22. PubMed ID: 21211368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of CYP1A1 and GSTM1 gene polymorphisms and BPDE-DNA adducts on lung cancer].
    Chen CM; Jin YT; Xu HY; Zhang CY; Zhang H; Zhang WM; Tan C; Sun XY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Feb; 29(1):23-7. PubMed ID: 22311486
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.
    Le Marchand L; Hankin JH; Wilkens LR; Pierce LM; Franke A; Kolonel LN; Seifried A; Custer LJ; Chang W; Lum-Jones A; Donlon T
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1259-66. PubMed ID: 11751443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.